Viewing Study NCT04476706


Ignite Creation Date: 2025-12-26 @ 4:02 PM
Ignite Modification Date: 2025-12-30 @ 5:42 AM
Study NCT ID: NCT04476706
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2021-02-03
First Post: 2020-07-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Canakinumab MAP in COVID-19 Pneumonia With CRS
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module